First Quadrant’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10,539
Closed -$91K 950
2017
Q2
$91K Sell
10,539
-3,879
-27% -$33.1K ﹤0.01% 776
2017
Q1
$128K Buy
14,418
+198
+1% +$1.84K ﹤0.01% 671
2016
Q4
$158K Hold
14,220
﹤0.01% 659
2016
Q3
$242K Buy
+14,220
New +$263K 0.01% 627

Other funds holding IRMD

First Quadrant's IRMD Position: Q3 2017 in Review

First Quadrant sold out of iRadimed (IRMD) in Q3 2017, closing a stake of 10,539 shares — an estimated $91K sold.

First Quadrant first reported a position in IRMD in Q3 2016 and held it in 4 quarters. The position peaked at $242K in Q3 2016. 29 funds tracked by Wall St. Rank hold IRMD as of Q3 2017.

  • First Quadrant reported no remaining iRadimed position as of Q3 2017 after selling out during the quarter.
  • First Quadrant sold 10,539 iRadimed shares in Q3 2017, an estimated $91K.
  • First Quadrant first reported a position in iRadimed in Q3 2016 and held it in 4 quarters.
  • First Quadrant's iRadimed position peaked at $242K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held iRadimed as of Q3 2017.

Based on First Quadrant's 13F filing for Q3 2017, filed 25 Oct 2017.